"This week in Other Barks & Bites: news reports indicate that the Department of Justice's (DOJ's) Weaponization Working Group is looking into Biden-era secret review processes for pharmaceutical and AI patents at the U.S. Patent and Trademark Office (USPTO); the Federal Circuit corrects the Trademark Trial and Appeal Board's (TTAB's) application of the DuPont factors with regards to the scope of similar goods and services; USPTO Director John Squires signals a commitment to patent eligibility for medical diagnostics and crypto patents in his first few"
"signed U.S. patents; President Donald Trump announces a 100% tariff for branded or patented pharmaceuticals unless companies build manufacturing facilities in the U.S.; Amazon is expected to pay a landmark $2.5 billion settlement with the Federal Trade Commission (FTC) over its deceptive Prime subscription enrollment practices; and U.S. District Judge William Alsup approves the major $1.5 billion settlement proposed in the copyright infringement case filed against AI developer Anthropic."
The PTAB de-designated SharkNinja Operating LLC v. iRobot Corporation, removing its December 2020 precedential status after the panel considered whether all real parties in interest were properly named. The DOJ's Weaponization Working Group is reportedly investigating Biden-era secret review processes for pharmaceutical and AI patents at the USPTO. The Federal Circuit corrected the TTAB's application of the DuPont factors regarding the scope of similar goods and services. USPTO Director John Squires signaled support for patent eligibility in medical diagnostics and crypto-related inventions. Major enforcement matters include a proposed $2.5 billion FTC settlement with Amazon and a $1.5 billion copyright settlement approved against Anthropic. A 100% tariff on branded or patented pharmaceuticals was announced, contingent on domestic manufacturing.
Read at IPWatchdog.com | Patents & Intellectual Property Law
Unable to calculate read time
Collection
[
|
...
]